Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases
by
Tsokos, George C
, Li, Hao
in
Connective tissues
/ Immune system
/ Inflammatory diseases
/ Interleukin 17
/ Interleukin 23
/ Molecular modelling
/ Rheumatic diseases
2021
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases
by
Tsokos, George C
, Li, Hao
in
Connective tissues
/ Immune system
/ Inflammatory diseases
/ Interleukin 17
/ Interleukin 23
/ Molecular modelling
/ Rheumatic diseases
2021
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases
2021
Request Book From Autostore
and Choose the Collection Method
Overview
In inflammatory rheumatic disorders, the immune system attacks and damages the connective tissues and invariably internal organs. During the past decade, remarkable advances having been made towards our understanding on the cellular and molecular mechanisms involved in rheumatic diseases. The discovery of IL-23/IL-17 axis and the delineation of its important role in the inflammation led to the introduction of many needed new therapeutic tools. We will present an overview of the rationale for targeting therapeutically the IL-23/IL-17 axis in rheumatic diseases and the clinical benefit which has been realized so far. Finally, we will discuss the complex interrelationship between IL-23 and IL-17 and the possible uncoupling in certain disease settings.
Publisher
Springer Nature B.V
This website uses cookies to ensure you get the best experience on our website.